Clinical Trial Update: The Efficacy of Escitalopram for Negative Symptoms in Schizophrenia [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the efficacy of escitalopram for negative symptoms in schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Lexapro (escitalopram)

Snippet

Sponsor: BeerYaakov Mental Health Center | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED